HSD17B4
protein-codinghydroxysteroid 17-beta dehydrogenase 4, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
The protein encoded by this gene is a bifunctional enzyme that is involved in the peroxisomal beta-oxidation pathway for fatty acids. It also acts as a catalyst for the formation of 3-ketoacyl-CoA intermediates from both straight-chain and 2-methyl-branched-chain fatty acids. Defects in this gene that affect the peroxisomal fatty acid beta-oxidation activity are a cause of D-bifunctional protein deficiency (DBPD). An apparent pseudogene of this gene is present on chromosome 8. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~184.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009300
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009300
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: Natera
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: Myriad Women's Health
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009855
Submitter: ClinGen
HSD17B4 was first reported in relation to autosomal recessive d-bifunctional protein deficiency in 1997 (Suzuki et al., PMID: 9345094). At least 14 unique variants (missense, nonsense, frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of case-level and experimental data: 14.5 points. Variants in this gene have been reported in at least 10 probands in 9 publications (PMIDs: 30396834, 11992265, 24553428, 23181892, 11743515, 20673864, 9345094, 9482850, 9915948). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism for disease is loss of function. This gene-disease association is supported by animal models and functional assays. In summary, HSD17B4 is definitively associated with autosomal recessive d-bifunctional protein deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability among the following disease entities: (1) D-bifunctional protein deficiency (MIM: 261515) and (2) Perrault syndrome 1 (MIM: 233400). Therefore, all of the disease entities have been lumped into one disease entity, d-bifunctional protein deficiency.
Inheritance Pattern: AR
Disease ID:MONDO:0017312
Submitter: ClinGen
The HSD17B4 gene has been associated with autosomal recessive Perrault syndrome using the ClinGen Clinical Validity Framework as of 1/10/2018. This association was made using case-level data only. At least 19 missense, nonsense, frameshift variants and splice-site variants have been reported in humans. HSD17B4 was first associated with this disease in humans as early as 2010 (Pierce et al.). Association was scored in at least 7 probands in 6 publications (20673864, 23181892, 24553428, 24602372, 28830375, 27790638). Perrault syndrome is characterized by ovarian dysgenesis in females and often azoospermia in males, as well as childhood to adult onset sensorineural hearing loss and ataxia. More severe types of DBP deficiency occur which cause severe phenotypes and infant mortality. That is outside the scope of this curation, but is important to note. Very little experimental evidence exists for HSD17B4 and Perrault syndrome. In summary, HSD17B4 is definitively associated with autosomal recessive Perrault syndrome.
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Endocrine; Genitourinary; Musculoskeletal; Neurologic; Obstetric
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
Comments: The condition may be clinically recognizable in females, and the exact onset of hearing loss is unclear, but evidence suggests a prelingual onset
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HSD17B4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000414.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 13 | 321 | 2 | 337 | |
| missense | 7 | 49 | 359 | 22 | 4 | 441 |
| nonsense | 24 | 26 | 50 | |||
| start loss | 4 | 4 | ||||
| frameshift | 29 | 80 | 5 | 114 | ||
| splice donor/acceptor (+/-2bp) | 5 | 70 | 13 | 88 | ||
| Total | 65 | 230 | 390 | 343 | 6 | 1034 |
Highest pathogenic variant AF is 0.00032841007
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000405.1 | 24 | MANE Select | |
| Ensembl | ENSP00000424940.3 | 24 | MANE Select | |
| RefSeq | NP_001186220.1 | 25 | Standard | |
| RefSeq | NP_001186221.1 | 23 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| hsd17b4 | Danio rerio | Structure: nucleate erythrocyte Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
- Primary bile acid biosynthesis - Homo sapiens (human)
- 27-Hydroxylase Deficiency
- Bile Acid Biosynthesis
- Congenital Bile Acid Synthesis Defect Type II
Biological Process
- very long-chain fatty acid metabolic process
- osteoblast differentiation
- protein targeting to peroxisome
- fatty acid beta-oxidation
- bile acid biosynthetic process
Molecular Function
- 3-hydroxyacyl-CoA dehydrogenase activity
- signaling receptor binding
- long-chain-enoyl-CoA hydratase activity
- isomerase activity
- 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity
Cellular Component
- peroxisome
- peroxisomal membrane
- peroxisomal matrix
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000504811
- Coding exons
- 25
- Length
- 184757
- Individuals with no LoFs
- 125696
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 52
- Defined
- 125748
- p
- 0.000207
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.275 | 426 | 410 | 1.04 | 0.0000209 | 4954 |
| Missense (PolyPhen) | 106 | 134.69 | 0.78699 | 1640 | ||
| Synonymous | -0.977 | 149 | 135 | 1.11 | 0.00000670 | 1453 |
| Loss of Function | 2.91 | 23 | 43.8 | 0.526 | 0.00000186 | 591 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00029 | 0.00029 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00023 | 0.00022 | rare |
| South Asian | 0.00029 | 0.00029 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Bifunctional enzyme acting on the peroxisomal beta- oxidation pathway for fatty acids. Catalyzes the formation of 3- ketoacyl-CoA intermediates from both straight-chain and 2-methyl- branched-chain fatty acids. {ECO:0000269|PubMed:8902629, ECO:0000269|PubMed:9089413}.;
- Disease
- DISEASE: Perrault syndrome 1 (PRLTS1) [MIM:233400]: A sex- influenced disorder characterized by sensorineural deafness in both males and females and ovarian dysgenesis in females. Some patients also have neurologic manifestations, including mild mental retardation and cerebellar and peripheral nervous system involvement. {ECO:0000269|PubMed:20673864}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.497
Intolerance Scores
- LoFtool
- 0.233
- RVIS EVS
- 0.27
- RVIS percentile EVS
- 70.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.853
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |